Since these factors are also increased in DR patients and implicated in the pathogenesis of retinopathy,[22] the reduced retinal pathogenesis observed upon TRAP1 inhibition might be associated with decreases in the levels of these factors, as well as those of VEGF, ANGPTL4, and ANG2. The gene discussed is ANGPTL4; the disease is retinal disorder.